These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19292074)

  • 1. [Radiofrequency ablation of malignant liver tumours].
    Drug VL; Bugioeanu C; Burcoveanu C; Balan G; Prelipcean CC; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):23-31. PubMed ID: 19292074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation of hepatocellular carcinoma.
    Curley SA; Izzo F
    Minerva Chir; 2002 Apr; 57(2):165-76. PubMed ID: 11941292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation of primary and metastatic hepatic malignancies.
    Curley SA; Izzo F
    Int J Clin Oncol; 2002 Apr; 7(2):72-81. PubMed ID: 12018113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation of malignant liver tumors.
    Curley SA
    Oncologist; 2001; 6(1):14-23. PubMed ID: 11161225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transdiaphragmatic radiofrequency ablation of malignant liver tumors].
    Takeda Y; Hasuike Y; Kashiwazaki M; Shin E; Tsujinaka T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2229-33. PubMed ID: 12484043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors in successful radiofrequency ablation therapy for malignant liver tumors.
    Sakakima Y; Inoue S; Takeda S; Kaneko T; Nakao A
    Hepatogastroenterology; 2004; 51(60):1761-5. PubMed ID: 15532821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of liver resection in combination with radiofrequency ablation for hepatic malignancies.
    Eisele RM; Zhukowa J; Chopra S; Schmidt SC; Neumann U; Pratschke J; Schumacher G
    Eur J Surg Oncol; 2010 Mar; 36(3):269-74. PubMed ID: 19726155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiofrequency ablation in primary and metastatic hepatic tumors].
    Rudzki S; Jamroz A
    Pol Merkur Lekarski; 2004 Jan; 16(91):86-9. PubMed ID: 15074031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors.
    Gannon CJ; Curley SA
    Semin Radiat Oncol; 2005 Oct; 15(4):265-72. PubMed ID: 16183480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
    Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI
    Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation of hepatic tumors: lessons learned from 3000 procedures.
    Rhim H; Lim HK; Kim YS; Choi D; Lee WJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1492-500. PubMed ID: 18713294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature.
    Garrean S; Hering J; Saied A; Helton WS; Espat NJ
    Am J Surg; 2008 Apr; 195(4):508-20. PubMed ID: 18361927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Standard treatment of liver malignancies with radiofrequency ablation].
    Chen MH; Yang W; Yan K; Gao W; Dai Y; Wang YB; Huo L; Zhang H; Huang XF
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1741-6. PubMed ID: 16253159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma.
    Nicoli N; Casaril A; Marchiori L; Mangiante G; Marini G; Colombari R; Portuese A; Hasheminia AR
    Chir Ital; 2000; 52(1):29-40. PubMed ID: 10832524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
    Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
    Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation of primary and metastatic liver tumors--4 years experience.
    Ribeiro MA; Rodrigues JJ; Habr-Gama A; Chaib E; D'Ipolitto G; Fonseca AZ; Saad WA; Saad WA
    Hepatogastroenterology; 2007 Jun; 54(76):1170-5. PubMed ID: 17629064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation of liver cancer.
    Lencioni R; Crocetti L
    Tech Vasc Interv Radiol; 2007 Mar; 10(1):38-46. PubMed ID: 17980317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.